- Home
- IMTE vs ADTX Comparison
IMTE vs ADTX Comparison
Compare IMTE & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMTE | ADTX |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5M | 2.1M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | IMTE | ADTX |
|---|---|---|
| Price | $0.83 | $3.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.0M | 1.7M |
| Earning Date | 09-26-2025 | 11-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $123,337.00 | $5,945.00 |
| Revenue This Year | N/A | $15,768.94 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.75 | N/A |
| 52 Week Low | $0.51 | $2.36 |
| 52 Week High | $3.17 | $10,311.20 |
Technical Indicators
Market Signals| Indicator | IMTE | ADTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.45 | 52.67 |
| Support Level | $0.70 | $2.65 |
| Resistance Level | $0.79 | $4.15 |
| Average True Range (ATR) | 0.08 | 0.62 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 65.85 | 60.89 |
Price Performance
Historical ComparisonAbout IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.